Teal Health raised $10 million in seed funding, taking its total funding to $23 million. The company has submitted an application to the FDA for its at-home cervical cancer screening kit, which seeks to give patients an alternative to the in-office pap smear.
The post Meet the Company Developing an At-Home Test to Replace the Pap Smear appeared first on MedCity News.
